The University of Chicago Header Logo

Connection

Janardan Khandekar to Dermatologic Agents

Back to Details
This is a "connection" page, showing publications Janardan Khandekar has written about Dermatologic Agents.
Janardan Khandekar
Connection Strength
0.124
Dermatologic Agents
  1. Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). Cancer. 2017 Dec 01; 123(23):4653-4662.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.